Artwork
iconShare
 
Manage episode 307932832 series 1163636
Content provided by ThinkResearch and Harvard Catalyst. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ThinkResearch and Harvard Catalyst or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
"The pathogen c.diff recurs in approximately 25% of patients within two months," says Georg Gerber, PhD, Brigham and Women's Hospital. In this podcast, Gerber reflects on the impact funding received from Harvard Catalyst has had on his research which focuses on recurring infections. Transcript: https://bit.ly/3pkMI2K
  continue reading

178 episodes